ENDO 2026 13 - 16 June 2026

3-Month Real-World Weight-Related Outcomes Among Patients Taking Oral Semaglutide 25 mg: Insights From the WeGoTogether Patient Support Solution App

Authors :

Wojciech Michalak¹; Jessica Muth¹; Sara Tadesse-Bell¹; Carmen Ng¹; Angela Fitch²

Affiliations

View Details Hide Details

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide (oral)

RWE